Pay attention to cholesterol-lowering statin intake guidelines - not brand names
BOSTON, MA –The market for cholesterol-lowering drugs is a multibillion dollar business. With the arrival of new statins, patients are faced with the question of which brand is the best. The December issue of Harvard Heart Letter dissects the myriad of choices and equips readers with sound ways to maximize the benefits of statins, regardless of their brand.
Although the six leading statins on the market target the same step in the cholesterol-making process, there are differences between them. To help readers distinguish among the selection, the December issue of Harvard Heart Letter examines these leading statins based on potency, proof of benefits, cost, and side effects.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.